| GC61217-50mg |
|
— |
Protein kinase inhibitors 1 hydrochloride
|
0 |
— |
|
|
|
| GC61217-25mg |
|
— |
Protein kinase inhibitors 1 hydrochloride
|
0 |
— |
|
|
|
| GC61217-10mg |
|
— |
Protein kinase inhibitors 1 hydrochloride
|
0 |
— |
|
|
|
| GC61217-5mg |
|
— |
Protein kinase inhibitors 1 hydrochloride
|
0 |
— |
|
|
|
| GC61217-10mM (in 1mL DMSO) |
|
— |
Protein kinase inhibitors 1 hydrochloride
|
0 |
— |
|
|
|
| GC61215-25mg |
|
2089205-64-9 |
|
0 |
— |
|
|
|
| GC61215-10mg |
|
2089205-64-9 |
|
0 |
— |
|
|
|
| GC61215-5mg |
|
2089205-64-9 |
|
0 |
— |
|
|
|
| GC61215-10mM (in 1mL DMSO) |
|
2089205-64-9 |
|
0 |
— |
|
|
|
| GC61214-100mg |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61214-50mg |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61214-25mg |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61214-10mg |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61214-5mg |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61214-10mM (in 1mL DMSO) |
|
— |
PROTAC BRD9-binding moiety 1 hydrochloride
|
0 |
— |
|
|
|
| GC61213-10mg |
|
— |
PROTAC BRD4 Degrader-5-CO-PEG3-N3
|
0 |
— |
|
|
|
| GC61212-10mg |
|
2409538-70-9 |
|
0 |
— |
|
|
|
| GC61211-100mg |
|
1957234-97-7 |
|
0 |
— |
|
|
|
| GC61211-50mg |
|
1957234-97-7 |
|
0 |
— |
|
|
|
| GC61211-25mg |
|
1957234-97-7 |
|
0 |
— |
|
|
|
